Burg C - Search Results

1

Involvement of histo-blood-group antigens in the susceptibility of colon carcinoma cells to natural killer-mediated cytotoxicity.

Blottière HM, Burg C, Zennadi R, Perrin P, Blanchardie P, Bara J, Meflah K, Le Pendu J. Blottière HM, et al. Among authors: burg c. Int J Cancer. 1992 Oct 21;52(4):609-18. doi: 10.1002/ijc.2910520420. Int J Cancer. 1992. PMID: 1399144

2

[Characterization of autoantigen (p105) in a model of colonic adenocarcinoma in the rat].

Blottière HM, Ménoret A, Burg C, Douillard JY, Meflah K, Le Pendu J. Blottière HM, et al. Among authors: burg c. Bull Cancer. 1992;79(1):47-53. Bull Cancer. 1992. PMID: 1520951 French.

3

Relationship between sensitivity to natural killer cells and MHC class-I antigen expression in colon carcinoma cell lines.

Blottière HM, Zennadi R, Burg C, Douillard JY, Meflah K, Le Pendu J. Blottière HM, et al. Among authors: burg c. Int J Cancer. 1992 Feb 20;50(4):659-64. doi: 10.1002/ijc.2910500430. Int J Cancer. 1992. PMID: 1537634

4

Identification and characterization of a rat protein (p 105) auto-antigenic in rats bearing a progressive syngeneic colon carcinoma.

Blottière HM, Menoret A, Burg C, Douillard JY, Le Pendu J. Blottière HM, et al. Among authors: burg c. Int J Cancer. 1992 Jan 21;50(2):315-20. doi: 10.1002/ijc.2910500225. Int J Cancer. 1992. PMID: 1730526

5

Failure of monoclonal antibodies against tumor associated antigens to improve tumor targeting of LAK cells in a model of rat colon carcinoma.

Zennadi R, Blottière MH, Burg C, Le Pendu J, Douillard JY. Zennadi R, et al. Among authors: burg c. Bull Cancer. 1993 Aug;80(8):674-9. Bull Cancer. 1993. PMID: 8204947

6

Co-segregation of tumor immunogenicity with expression of inducible but not constitutive hsp70 in rat colon carcinomas.

Ménoret A, Patry Y, Burg C, Le Pendu J. Ménoret A, et al. Among authors: burg c. J Immunol. 1995 Jul 15;155(2):740-7. J Immunol. 1995. PMID: 7608552

7

An interleukin 2/sodium butyrate combination as immunotherapy for rat colon cancer peritoneal carcinomatosis.

Perrin P, Cassagnau E, Burg C, Patry Y, Vavasseur F, Harb J, Le Pendu J, Douillard JY, Galmiche JP, Bornet F, et al. Perrin P, et al. Among authors: burg c. Gastroenterology. 1994 Dec;107(6):1697-708. doi: 10.1016/0016-5085(94)90810-9. Gastroenterology. 1994. PMID: 7958681

8

Leukaemia Inhibitory Factor derived from rat colon carcinoma cells increases host susceptibility to tumour growth.

Burg C, Patry Y, Le Pendu J, Moreau M, Tesson L, Godard A, Soulillou JP, Meflah K, Anegon I. Burg C, et al. Cytokine. 1995 Nov;7(8):784-92. doi: 10.1006/cyto.1995.0094. Cytokine. 1995. PMID: 8664445

9

[Treatment with butyrate/IL-2 combination in peritoneal carcinomatosis of colonic origin].

Perrin P, Burg C, Vavasseur F, Galmiche JP, Bornet F, Meflah K. Perrin P, et al. Among authors: burg c. C R Acad Sci III. 1993 Jun;316(6):611-4. C R Acad Sci III. 1993. PMID: 8019883 French.

10

Monoclonal antibodies to a rat colon carcinoma: model for monoclonal antibody therapy of solid tumors.

Douillard JY, Laborda J, Burg C, Ridge J, Levenbook I, Blottière H, Sela B, Hoffman T. Douillard JY, et al. Among authors: burg c. Cancer Res. 1989 Feb 1;49(3):687-92. Cancer Res. 1989. PMID: 2910489

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

147 results

Search Page

Filters